The University of British Columbia
UBC - A Place of Mind
The University of British Columbia
Faculty of Medicine
  • Home
  • Admissions
  • About
    • Strategic Plan
    • Vision & Values
    • Land Acknowledgement
    • Indigenous Health
    • Leadership
    • Academic & Research Units
    • Campuses
    • Facts & Figures
    • Careers
    • Contact
  • News
    • Feature Stories
    • Pathways Magazine
    • The Next Big Question
  • Education
    • Programs
    • Faculty Development
    • Health Education Scholarship
    • Continuing Professional Development
  • Research
    • Priority Areas
    • Canada’s Immuno-Engineering and Biomanufacturing Hub
    • COVID-19 Clinical Research Coordination Initiative
    • Academy of Translational Medicine
    • Edwin S.H. Leong Centre for Healthy Aging
    • Centres & Institutes
    • National Prizes
  • Giving
    • Impact of Giving
    • By the Numbers
    • Ways to Give
    • Webinar Series
    • Contact Us
  • Prospective Students
  • Current Learners
    • Policies & Procedures
    • Respectful Environments, Equity, Diversity & Inclusion
    • Mistreatment Help
    • MD & Undergrad Research
    • Summer Student Research Program
    • Multidisciplinary Research Program in Medicine
    • Grad & Postdoc Education
  • Faculty & Staff
  • Clinical Faculty
    • Becoming Clinical Faculty
    • Appointment Policy & Compensation Terms
    • Teaching Tracking & Payment System
    • Services & Perks
    • Career Development
    • Awards
    • Celebrating Clinical Faculty
    • Advisory Council
    • Contacts
  • Alumni
» Home » News » UBC faculty of medicine researchers receive more than $5M as part of Canada’s largest investment in clinical trials

Contact

Communications
UBC Faculty of Medicine
Email: communications.med@ubc.ca
Office: 604.822.2421

UBC faculty of medicine researchers receive more than $5M as part of Canada’s largest investment in clinical trials

By Qian Chow | February 3, 2023

UBC faculty of medicine researchers have been awarded federal funding as part of Canada’s largest-ever investment in clinical trials.

The Canadian Institutes of Health Research Clinical Trials Fund (CTF) dedicated $250 million across three funding streams to grow and strengthen Canada’s clinical trials infrastructure, training, and research through 2025.

Approximately $60M is being awarded to 22 projects to fund clinical trial phases, designs, and objectives that align with the priorities of the Biomanufacturing and Life Sciences Strategy, including the two UBC-led projects for a total of over $5.5 million.

“Clinical trials help get lifesaving drugs to market. With these new investments, Canadian researchers will have an opportunity to innovate and develop much-needed treatments right here in Canada,” said the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry. “Strengthening the clinical trials ecosystem is an essential part of our government’s Biomanufacturing and Life Sciences Strategy, better preparing us for the future.”

Faculty of medicine recipients and their projects:

Dr. Kevin A. Hay


Dr. Kevin A. Hay, division of hematology, department of medicine

A Phase I trial of single domain antibody-based CD22 chimeric antigen receptor (CAR)-T cells for the treatment of relapsed/refractory CD22+ B-cell acute lymphoblastic leukemia

Dr. Srinivas Murthy


Dr. Srinivas Murthy, department of pediatrics

Randomized Embedded Multifactorial Adaptive Platform Trial of Community Acquired Pneumonia

Contact Information

Communications
UBC Faculty of Medicine
Email: communications.med@ubc.ca
Office: 604.822.2421
Faculty of Medicine
317 - 2194 Health Sciences Mall
Vancouver, BC Canada V6T 1Z3
Tel 604 822 2421
Website www.med.ubc.ca
Find us on
    
Back to top
The University of British Columbia
  • Emergency Procedures |
  • Terms of Use |
  • Copyright |
  • Accessibility